These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 2138428
1. Physiological regulation of the renal vasopressin receptor-effector pathway in dogs. Kinter LB, Caldwell N, Caltabiano S, Winslow C, Brooks DP, Huffman WF. Am J Physiol; 1990 Mar; 258(3 Pt 2):R763-9. PubMed ID: 2138428 [Abstract] [Full Text] [Related]
2. Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogs. Albrightson-Winslow CR, Caldwell N, Brooks DP, Huffman WF, Stassen FL, Kinter LB. J Pharmacol Exp Ther; 1989 May; 249(2):366-71. PubMed ID: 2524585 [Abstract] [Full Text] [Related]
3. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs. Naitoh M, Suzuki H, Murakami M, Matsumoto A, Ichihara A, Nakamoto H, Yamamura Y, Saruta T. Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468 [Abstract] [Full Text] [Related]
4. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs. Liard JF. Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987 [Abstract] [Full Text] [Related]
5. Up-regulation of renal adenylate cyclase-coupled vasopressin receptors after chronic administration of vasopressin antagonists to rats. Caltabiano S, Kinter LB. J Pharmacol Exp Ther; 1991 Sep; 258(3):1046-54. PubMed ID: 1832462 [Abstract] [Full Text] [Related]
6. Effect of V1/V2-receptor antagonism on renal function and response to vasopressin in conscious dogs. Rose CE, Rose KY, Kinter LB. Am J Physiol; 1991 Feb; 260(2 Pt 2):F273-82. PubMed ID: 1825453 [Abstract] [Full Text] [Related]
7. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin. Ervin MG, Ross MG, Leake RD, Fisher DA. Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929 [Abstract] [Full Text] [Related]
8. Mechanism of vasopressin natriuresis in the dog: role of vasopressin receptors and prostaglandins. Kompanowska-Jezierska E, Emmeluth C, Grove L, Christensen P, Sadowski J, Bie P. Am J Physiol; 1998 Jun; 274(6):R1619-25. PubMed ID: 9608016 [Abstract] [Full Text] [Related]
9. Effect of cyclo-oxygenase blockade on the renal actions of vasopressin and SK&F 105494 in the rhesus monkey. Brooks DP, Caldwell NC, Koster PF, Albrightson-Winslow CR, Kinter LB. Br J Pharmacol; 1990 Apr; 99(4):750-2. PubMed ID: 2113824 [Abstract] [Full Text] [Related]
10. Hypotension during vasopressin receptor blockade: role of V2 receptors and sympathetic nervous system. Brooks VL, Hatton DC. Am J Physiol; 1991 Jun; 260(6 Pt 2):H1878-87. PubMed ID: 1829332 [Abstract] [Full Text] [Related]
11. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs. Liard JF. Circ Res; 1986 May; 58(5):631-40. PubMed ID: 3754791 [Abstract] [Full Text] [Related]
12. Thirst impairment elicited by intraventricular administration of vasopressin antagonists. Szczepanska-Sadowska E, Sobocinska J, Kozłowski S. Peptides; 1987 May; 8(6):1003-9. PubMed ID: 2964590 [Abstract] [Full Text] [Related]
13. Discovery and therapeutic utility of vasopressin antagonists in rats. Kinter LB, Dytko G, Ashton D, McDonald J, Huffman W, Stassen F. J Cardiovasc Pharmacol; 1986 May; 8 Suppl 7():S36-43. PubMed ID: 2434770 [Abstract] [Full Text] [Related]